Use of powerful CYP1A2 inhibitors ought to be discontinued prior to initiating pirfenidone and prevented for the duration of therapy; if potent CYP1A2 inhibitors are the sole drug of choice, dosage reductions are advisable Utilization of robust CYP1A2 inhibitors need to be discontinued right before initiating procedure and averted through https://yasunarih555vgr7.blogsumer.com/profile